Premium
Antidepressants block effect of D‐cycloserine in OCD treatment
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30101
Subject(s) - cycloserine , placebo , psychopharmacology , partial agonist , antidepressant , psychology , concomitant , medicine , psychiatry , pharmacology , psychotherapist , clinical psychology , anxiety , agonist , alternative medicine , tuberculosis , receptor , pathology
The effects of the partial N‐methyl‐D‐aspartate (NMDA) agonist D‐cycloserine in augmenting cognitive behavioral therapy (CBT) in patients with obsessive‐compulsive disorder (OCD) were blocked in individuals taking an antidepressant concurrently, a new study has found. Concomitant antidepressant use did not have any effect in a group of patients receiving placebo in the study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom